Home / CometAssays / CometAssay HT Sample Kit

CometAssay HT Sample Kit

4252-040-K 22 Citations Datasheet / COA / SDS
Catalog # Availability Size / Price Qty
4252-040-K
Product Details
Citations (22)
FAQs
Reviews
Summary Product Datasheets Background

CometAssay HT Sample Kit Summary

Includes two specially treated 20-well CometSlides and sufficient reagents for 40 test samples.

Key Benefits

• Specially treated slides to promote agarose adherence
• Ready to use low melt agarose (LMAgarose) in convenient size
• Lysis Solution suitable for either alkaline or neutral comet assay
• Optimized electrophoresis conditions

Product Specifications

  • Applicable for the analysis of either single- or double-strand DNA breaks
  • Study cellular responses to DNA damage
  • Screen for inhibitors of DNA repair
  • Test chemicals for toxicity
  • Screen for environmental mutagens

Kit Contents

• CometAssay Lysis Solution
• CometAssay LMAgarose
• 200 mM EDTA, pH 10
• CometSlides (20 Well, 2 Slides)

Specifications

Shipping Conditions
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended on the label.
Storage
Store the unopened product at room temperature. Do not use past expiration date.
Species
N/A

Limitations

For research use only. Not for diagnositic use.

Product Datasheets

Product Datasheet
COA
SDS

Citations for CometAssay HT Sample Kit

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

22 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Dianhydrogalactitol synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells
    Authors: B Zhai, Y Li, SS Kotapalli, J Bacha, D Brown, A Steinø, M Daugaard
    Cell Death Dis, 2020;11(7):577.  2020
  2. Genome-wide CRISPR-Cas9 screen reveals selective vulnerability of ATRX-mutant cancers to WEE1 inhibition
    Authors: J Liang, H Zhao, BH Diplas, S Liu, J Liu, D Wang, Y Lu, Q Zhu, J Wu, W Wang, H Yan, YX Zeng, X Wang, Y Jiao
    Cancer Res., 2019;0(0):.  2019
  3. The human Shu complex functions with PDS5B and SPIDR to promote homologous recombination
    Authors: J Martino, GJ Brunette, J Barroso-Go, TN Moiseeva, CM Smith, CJ Bakkenist, RJ O'Sullivan, KA Bernstein
    Nucleic Acids Res., 2019;47(19):10151-10165.  2019
  4. Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment.
    Authors: Gatti L, Cossa G, Tinelli S, Carenini N, Arrighetti N, Pennati M, Cominetti D, de Cesare M, Zunino F, Zaffaroni N, Perego P
    J Pharmacol Exp Ther, 2014;348(3):360-71.  2014
  5. Uracil-DNA glycosylase expression determines human lung cancer cell sensitivity to pemetrexed.
    Authors: Weeks L, Fu P, Gerson S
    Mol Cancer Ther, 0;12(10):2248-60.  0
  6. Intracellular deoxyribonucleotide pool imbalance and DNA damage in cells treated with hydroxyurea, an inhibitor of ribonucleotide reductase.
    Authors: Osterman Golkar S, Czene S, Gokarakonda A, Haghdoost S
    Mutagenesis, 0;28(6):653-60.  0
  7. CREB-binding protein regulates Ku70 acetylation in response to ionization radiation in neuroblastoma.
    Authors: Subramanian C, Hada M, Opipari A, Castle V, Kwok R
    Mol Cancer Res, 0;11(2):173-81.  0
  8. Potential new mechanisms of placental damage in celiac disease: anti-transglutaminase antibodies impair human endometrial angiogenesis.
    Authors: Di Simone N, De Spirito M, Di Nicuolo F, Tersigni C, Castellani R, Silano M, Maulucci G, Papi M, Marana R, Scambia G, Gasbarrini A
    Biol Reprod, 0;89(4):88.  0
  9. Combining PARP-1 inhibition and radiation in Ewing sarcoma results in lethal DNA damage.
    Authors: Lee H, Yoon C, Schmidt B, Park D, Zhang A, Erkizan H, Toretsky J, Kirsch D, Yoon S
    Mol Cancer Ther, 0;12(11):2591-600.  0
  10. Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibody.
    Authors: Song H, Hedayati M, Hobbs R, Shao C, Bruchertseifer F, Morgenstern A, Deweese T, Sgouros G
    Mol Cancer Ther, 0;12(10):2043-54.  0
  11. EGFR-activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivity.
    Authors: Pfaffle H, Wang M, Gheorghiu L, Ferraiolo N, Greninger P, Borgmann K, Settleman J, Benes C, Sequist L, Zou L, Willers H
    Cancer Res, 0;73(20):6254-63.  0
  12. Radioprotective properties of tocopherol succinate against ionizing radiation in mice.
    Authors: Singh V, Singh P, Wise S, Posarac A, Fatanmi O
    J Radiat Res, 0;54(2):210-20.  0
  13. A hormone-DNA repair circuit governs the response to genotoxic insult.
    Authors: Goodwin J, Schiewer M, Dean J, Schrecengost R, de Leeuw R, Han S, Ma T, Den R, Dicker A, Feng F, Knudsen K
    Cancer Discov, 0;3(11):1254-71.  0
  14. Preclinical activity profile and therapeutic efficacy of the HSP90 inhibitor ganetespib in triple-negative breast cancer.
    Authors: Proia D, Zhang C, Sequeira M, Jimenez J, He S, Spector N, Shapiro G, Tolaney S, Nagai M, Acquaviva J, Smith D, Sang J, Bates R, El-Hariry I
    Clin Cancer Res, 0;20(2):413-24.  0
  15. Cell cycle stage-specific roles of Rad18 in tolerance and repair of oxidative DNA damage.
    Authors: Yang Y, Durando M, Smith-Roe S, Sproul C, Greenwalt A, Kaufmann W, Oh S, Hendrickson E, Vaziri C
    Nucleic Acids Res, 0;41(4):2296-312.  0
  16. Thirdhand smoke causes DNA damage in human cells.
    Authors: Hang B, Sarker A, Havel C, Saha S, Hazra T, Schick S, Jacob P, Rehan V, Chenna A, Sharan D, Sleiman M, Destaillats H, Gundel L
    Mutagenesis, 0;28(4):381-91.  0
  17. Physiological modulation of endogenous BRCA1 p220 abundance suppresses DNA damage during the cell cycle.
    Authors: Dimitrov S, Lu D, Naetar N, Hu Y, Pathania S, Kanellopoulou C, Livingston D
    Genes Dev, 0;27(20):2274-91.  0
  18. Dual functions of the homeoprotein DLX4 in modulating responsiveness of tumor cells to topoisomerase II-targeting drugs.
    Authors: Trinh B, Ko S, Barengo N, Lin S, Naora H
    Cancer Res, 0;73(2):1000-10.  0
  19. Lobarstin enhances chemosensitivity in human glioblastoma T98G cells.
    Authors: Kim S, Jo S, Lee H, Kim T, Kim I, Yim J, Chung H
    Anticancer Res, 0;33(12):5445-51.  0
  20. LORD-Q: a long-run real-time PCR-based DNA-damage quantification method for nuclear and mitochondrial genome analysis.
    Authors: Lehle S, Hildebrand D, Merz B, Malak P, Becker M, Schmezer P, Essmann F, Schulze-Osthoff K, Rothfuss O
    Nucleic Acids Res, 0;42(6):e41.  0
  21. Identification and characterization of a potent activator of p53-independent cellular senescence via a small-molecule screen for modifiers of the integrated stress response.
    Authors: Sayers C, Papandreou I, Guttmann D, Maas N, Diehl J, Witze E, Koong A, Koumenis C
    Mol Pharmacol, 0;83(3):594-604.  0
  22. hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1.
    Authors: Zheng H, Yang L, Peng L, Izumi V, Koomen J, Seto E, Chen J
    Mol Cell Biol, 0;33(24):4960-70.  0

FAQs

No product specific FAQs exist for this product, however you may

View all FAQs

Reviews for CometAssay HT Sample Kit

There are currently no reviews for this product. Be the first to review CometAssay HT Sample Kit and earn rewards!

Have you used CometAssay HT Sample Kit?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review